Current opinions on the role of pathogen reduction technology in improving the viral safety of blood and derivatives

被引：0
|
作者：
Seghatchian, Jerard [1 ]
机构：
[1] Blood Components Apheresis Technol & Haemostasis, London NW3 3AA, England
来源：
TRANSFUSION AND APHERESIS SCIENCE | 2008年 / 39卷 / 01期
关键词：
D O I：
10.1016/j.transci.2008.05.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [31] Pathogen Reduction Technology: A Novel Possibility for Inactivation of Blood Products Used in Oral and Periodontal Surgeries
    Varma, Sudhir Rama
    Jaber, Mohamed
    Abu Fanas, Salem
    Desai, Vijay
    Thomas, Sam
    Khair, Moutassem
    [J]. JOURNAL OF INTERNATIONAL SOCIETY OF PREVENTIVE AND COMMUNITY DENTISTRY, 2020, 10 (06): : 713 - 718
  • [32] Remodelling whole blood processing through automation and pathogen reduction technology at the Luxembourg Red Cross
    Malvaux, Nicolas
    Schuhmacher, Anne
    Defraigne, Fanette
    Jacob, Remy
    Bah, Aicha
    Cardoso, Marcia
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (05)
  • [33] Development of blood transfusion product pathogen reduction treatments: A review of methods, current applications and demands
    Salunkhe, Vishal
    van der Meer, Pieter F.
    de Korte, Dirk
    Seghatchian, Jerard
    Gutierrez, Laura
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2015, 52 (01) : 19 - 34
  • [34] A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology
    Cazenave, J. -P
    Follea, G.
    Bardiaux, L.
    Boiron, J. -M.
    Lafeuillade, B.
    Debost, M.
    Lioure, B.
    Harousseau, J. -L.
    Tabrizi, R.
    Cahn, J. -Y
    Michallet, M.
    Ambruso, D.
    Schots, R.
    Tissot, J. -D.
    Sensebe, L.
    Kondo, T.
    McCullough, J.
    Rebulla, P.
    Escolar, G.
    Mintz, P.
    Heddle, N. M.
    Goodrich, R. P.
    Bruhwyler, J.
    Le, C.
    Cook, R. J.
    Stouch, B.
    [J]. TRANSFUSION, 2010, 50 (11) : 2362 - 2375
  • [35] Inactivation of human white blood cells in red blood cell products using Mirasol® pathogen reduction technology (PRT).
    Fast, Loren D.
    Marschner, Susanne
    DiLeone, Gilbert
    Doane, Suzann K.
    Goodrich, Raymond P.
    [J]. BLOOD, 2006, 108 (11) : 113B - 114B
  • [36] Mirasol™ pathogen reduction technology for blood products using riboflavin and UV illumination:: Mode of action of riboflavin on pathogen nucleic acid chemistry
    Kumar, V
    McLean, R
    Keil, S
    Gilmour, D
    Luzniak, G
    Lockerbie, O
    Rice, J
    Jansenns, M
    Goodrich, R
    [J]. TRANSFUSION, 2003, 43 (09) : 79A - 79A
  • [37] Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation
    Reddy, Heather L.
    Dayan, Anthony D.
    Cavagnaro, Joy
    Gad, Shayne
    Li, Junzhi
    Goodrich, Raymond P.
    [J]. TRANSFUSION MEDICINE REVIEWS, 2008, 22 (02) : 133 - 153
  • [38] Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro
    Cap, Andrew P.
    Pidcoke, Heather F.
    Keil, Shawn D.
    Staples, Hilary M.
    Anantpadma, Manu
    Carrion, Ricardo, Jr.
    Davey, Robert A.
    Frazer-Abel, Ashley
    Taylor, Audra L.
    Gonzales, Richard
    Patterson, Jean L.
    Goodrich, Raymond P.
    [J]. TRANSFUSION, 2016, 56 : S6 - S15
  • [39] The Role of Technology in Enhancing Adolescent Online Safety: Current Trends and Future Directions
    Mwijage, Tajuddin
    Ghosh, Arup
    [J]. SOUTHEASTCON 2024, 2024, : 1610 - 1614
  • [40] Less is (sometimes) more in cognitive engineering: the role of automation technology in improving patient safety
    Vicente, KJ
    [J]. QUALITY & SAFETY IN HEALTH CARE, 2003, 12 (04): : 291 - 294
12345